![Nicholas Grund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Grund
Företagsledare/Principal på
AKEBIA THERAPEUTICS, INC.
Förmögenhet: 337 330 $ per 2026-05-31
Profil
Nicholas P.
Grund is Chief Commercial Officer & Senior Vice President at Akebia Therapeutics, Inc. since 2024.
Formerly, Mr. Grund was Head-Specialty Care at Genzyme Corp.
from 2007 to 2015, Chief Commercial Officer & Executive VP at AMAG Pharmaceuticals, Inc. from 2016 to 2019, President-Eurofins at Transplant Genomics, Inc. from 2021 to 2022, and Principal at Bayer Diagnostics Corp.
from 1995 to 2002.
Mr. Grund earned an MBA from Northeastern University and completed undergraduate studies at the University of Massachusetts.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-31 | 330 716 ( 0,12 % ) | 337 330 $ | 2026-05-31 |
Aktiva positioner av Nicholas Grund
| Företag | Position | Start |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Företagsledare/Principal | 2024-01-09 |
Tidigare kända positioner av Nicholas Grund
| Företag | Position | Slut |
|---|---|---|
Transplant Genomics, Inc.
 Transplant Genomics, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which focuses on kidney transplant recipients | Företagsledare/Principal | 2022-11-01 |
| AMAG PHARMACEUTICALS, INC. | Företagsledare/Principal | 2019-03-29 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Företagsledare/Principal | 2015-12-01 |
Bayer Diagnostics Corp.
 Bayer Diagnostics Corp. Medical SpecialtiesHealth Technology Provides diagnostic and research services | Företagsledare/Principal | 2002-01-01 |
Nicholas Grunds utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
74
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Bayer Diagnostics Corp.
Bayer Diagnostics Corp. Medical SpecialtiesHealth Technology Provides diagnostic and research services | Health Technology |
Transplant Genomics, Inc.
Transplant Genomics, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which focuses on kidney transplant recipients | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
